| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/27/2003 | WO2003016520A1 Anti-aging and wound healing compounds |
| 02/27/2003 | WO2003016519A1 METHOD FOR CLONING AND EXPRESSION OF AsiSI RESTRICTION ENDONUCLEASE AND AsiSI METHYLASE IN E.COLI |
| 02/27/2003 | WO2003016518A1 Regulation of human triacylglycerol lipase |
| 02/27/2003 | WO2003016517A2 Kinase crystal structures |
| 02/27/2003 | WO2003016516A2 Kinase crystal structures and materials and methods for kinase activation |
| 02/27/2003 | WO2003016515A2 Regulation of human glycerol-3-phosphate acyltransferase-like protein |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016498A2 Molecular interaction sites of rnase p rna and methods of modulating the same |
| 02/27/2003 | WO2003016492A2 Adamts13 genes and proteins and variants, and uses thereof |
| 02/27/2003 | WO2003016485A2 Full-length serine protein kinase in brain and pancreas |
| 02/27/2003 | WO2003016482A2 Methyltransferase genes and uses thereof |
| 02/27/2003 | WO2003016475A2 Nucleic acid and amino acid sequences involved in pain |
| 02/27/2003 | WO2003016474A2 Methods and compositions for use in selectively producing a protein in telomerase expressing cells |
| 02/27/2003 | WO2003016338A1 Crystal structure of the btk kinase domain |
| 02/27/2003 | WO2003016328A1 Methods for the treatment and prevention of cancer |
| 02/27/2003 | WO2003015790A1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 02/27/2003 | WO2003015692A2 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same |
| 02/27/2003 | WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | WO2003015501A1 3-deoxy-d-manno-octulosonic acid 8-phosphate synthases |
| 02/27/2003 | WO2002103000A3 Methods for modulating gap junctions |
| 02/27/2003 | WO2002101052A3 Salutaridinol 7-o-acetyltransferase and derivatives thereof |
| 02/27/2003 | WO2002092134A8 Lentiviral vectors encoding clotting factors for gene therapy |
| 02/27/2003 | WO2002086091A3 Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector |
| 02/27/2003 | WO2002086088A3 Polymerases with charge-switch activity and methods of generating such polymerases |
| 02/27/2003 | WO2002083064A3 A method of treating cancer |
| 02/27/2003 | WO2002077181A3 Adenylyl and guanylyl cyclases |
| 02/27/2003 | WO2002077171A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/27/2003 | WO2002077167A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/27/2003 | WO2002072846A3 Synthetic genes and bacterial plasmids devoid of cpg |
| 02/27/2003 | WO2002072752A3 Forms of prostate specific antigens and methods for their detection |
| 02/27/2003 | WO2002072751A3 Polynucleotides encoding a metalloprotease, mp-1 |
| 02/27/2003 | WO2002072006A3 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 02/27/2003 | WO2002070709A3 Molecules for disease detection and treatment |
| 02/27/2003 | WO2002068620A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/27/2003 | WO2002064839A3 Methods for the diagnosis and treatment of tumors employing the hepsin gene |
| 02/27/2003 | WO2002064815A3 33945, a human glycosyltransferase family member and uses therefor |
| 02/27/2003 | WO2002064736A3 Protein-protein interactions |
| 02/27/2003 | WO2002060951A3 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 02/27/2003 | WO2002057464A3 Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs |
| 02/27/2003 | WO2002057422A3 Ternary biomolecule/polymer/surface-based immobilization systems |
| 02/27/2003 | WO2002055725A3 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 02/27/2003 | WO2002055714A3 Human protease and polynucleotides encoding the same |
| 02/27/2003 | WO2002053755A3 Regulation of human otu-like cysteine protease |
| 02/27/2003 | WO2002053716A3 Regulation of human ornithine decarboxylase |
| 02/27/2003 | WO2002048375A3 Purified active hcv ns2/3 protease |
| 02/27/2003 | WO2002048329A3 Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
| 02/27/2003 | WO2002048328A3 Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002038747A3 Human adenylate cyclase |
| 02/27/2003 | WO2002033093A3 Aggrecanase molecules |
| 02/27/2003 | WO2002033061A3 32229, a human acyl-coa dehydrogenase family member and uses thereof |
| 02/27/2003 | WO2002031161A3 Regulation of human phospholipase-like enzyme |
| 02/27/2003 | WO2002031124A3 Alpha-amylase variant with altered properties |
| 02/27/2003 | WO2002026945A3 Regulation of human aminotransferase-like enzyme |
| 02/27/2003 | WO2002018607A3 Transgenic plants containing molecular decoys that alter protein content therein |
| 02/27/2003 | WO2002018555A3 Human kinase proteins and polynucleotides encoding the same |
| 02/27/2003 | WO2002010459A3 Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof |
| 02/27/2003 | WO2002008716A3 Method for screening peptides for use in immunotherapy |
| 02/27/2003 | WO2002008269A3 A cytochrome p450 enzyme associated with the synthesis of δ12-epoxy groups in fatty acids of plants |
| 02/27/2003 | WO2002004022A8 High fidelity polymerases and uses thereof |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002001950A3 Transgenic mice containing targeted gene disruptions |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098543A3 Method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001090160A3 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| 02/27/2003 | WO2001085924A3 MODULATION OF η-SECRETASE ACTIVITY |
| 02/27/2003 | US20030041357 Nucleotide sequences coding polypeptide for use in the generation of disease, insect and herbicide resistant plants |
| 02/27/2003 | US20030041351 Cotton plants with improved cotton fiber characteristics and method for producing cotton fibers from these cotton plants |
| 02/27/2003 | US20030041346 Cytochrome P450 monooxygenases |
| 02/27/2003 | US20030041345 Nucleotide sequences coding enzymatic polypeptide for use in the propagation of plants |
| 02/27/2003 | US20030041342 Nucleotide sequences for use in the propagation of agricultural crops |
| 02/27/2003 | US20030041340 Animal model for fatty acid amide-related neurobehaviors |
| 02/27/2003 | US20030041338 Mevalonate synthesis enzymes |
| 02/27/2003 | US20030041337 Animal model for use in the diagnosis and treatment of diabetic phenotype |
| 02/27/2003 | US20030040614 Generation of enzyme containing polypeptides; obtain nucleotide sequences, mutagenize, express nucleotide sequences, recover mutant enzymatic polypeptides |
| 02/27/2003 | US20030040474 For therapy and prophylaxis of disorder characterized by the cellular proliferation |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040462 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance |
| 02/27/2003 | US20030040461 Providing a cell expressing Bruton's Tyrosine Kinase; contacting cell expressing Bruton's Tyrosine Kinase with a test compound; determining whether test compound modulates the activity of Bruton's Tyrosine Kinase |
| 02/27/2003 | US20030040450 For use in detergent |
| 02/27/2003 | US20030040098 Glutaminase, glutaminase gene, novel recombinant DNA, and process for manufacturing glutaminase |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040095 Generation of preferential protein for use in the trement of thrombosis and heart defscts; obtain cells, transform with vector containing preferential protein, recover transformed cells, propagate, recover protein |
| 02/27/2003 | US20030040094 ATP diphosphohydrolase for use in the treatment of pancreatic and heart disorders |
| 02/27/2003 | US20030040093 Platelet activating factor acetylhydrolase, and gene thereof |
| 02/27/2003 | US20030040092 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis of heart disorders |
| 02/27/2003 | US20030040091 Mutant 1,3-propanediol dehydrogenase |
| 02/27/2003 | US20030040090 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase |
| 02/27/2003 | US20030040084 Macrolide analogs |
| 02/27/2003 | US20030040079 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040053 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders and tumors |
| 02/27/2003 | US20030040049 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase |
| 02/27/2003 | US20030040041 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
| 02/27/2003 | US20030040040 Dna molecules for expression of bile salt-stimulated lipase |
| 02/27/2003 | US20030040037 In vitro modification of glycosylation patterns of recombinant glycopeptides |